New study explores digital tools to keep care going in crises

NCT ID NCT06735404

Not yet recruiting Knowledge-focused Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at whether a hybrid care model—using telemonitoring, teleconsultations, and online tools—can help patients with type 2 diabetes or chronic heart failure get regular care during health emergencies like pandemics. Researchers will follow 180 patients for one year, using surveys and interviews to see how patients feel about this approach. The goal is to learn if this model can reduce strain on healthcare systems while keeping patients safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hybrid care model (digital tools and task shifting)
What this could lead to: If successful, this could show that a mix of digital tools and remote care can keep regular care running smoothly during future health emergencies.
What could go wrong: This is a small feasibility study, not a large trial. It only measures patient experiences, not hard health outcomes, so results may not prove the model works for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 2 HEART FAILURE

Contacts and locations

Locations

Accademia Italiana Cure Primarie

Verona, Italy
Community Health Centre Ljubljana

Ljubljana, Slovenia
Radboud University Medical Center

Nijmegen, Netherlands
University of Malta

Valletta, Malta

More trials for these conditions

Other studies related to the condition(s) this trial covers.